18F-fluoromisonidazole positron emission tomography before treatment is a predictor of radiotherapy outcome and survival prognosis in patients with head and neck squamous cell carcinoma

Annals of Nuclear Medicine

Volumn 25, Issue 9, 2011, Pages 625-633

  Kikuchi, Masahiro ^a   Yamane, Tomohiko ^b   Shinohara, Shogo ^a   Fujiwara, Keizo ^a   Hori, Shin Ya ^c   Tona, Yosuke ^c   Yamazaki, Hiroshi ^a   Naito, Yasushi ^a   Senda, Michio ^b  

^a KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^b INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^c SHIZUOKA GENERAL HOSPITAL   (Japan)

Author keywords

18F fluoromisonidazole ( 18F FMISO); Head and neck cancer; Hypoxia; Positron emission tomography (PET); Prediction of prognosis

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HYPOXIA; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SURVIVAL;

ADULT; AGED; ANALYSIS OF VARIANCE; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MISONIDAZOLE; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 81855161827     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-011-0508-9     Document Type: Article

References (30)

1. RK Jain 2002 Tumor angiogenesis and accessibility: role of vascular endothelial growth factor Semin Oncol 29 3 9 12516032 1:CAS:528: DC%2BD3sXlvFSqsA%3D%3D
2. Piert M. Hypoxia Imaging. In: Wahl RL, editor. Principles and practice of PET and PET/CT. Philadelphia: Lippincott Williams and Wilkins; 2009. p. 464-71.
3. A Wouters B Pauwels F Lardon JB Vermorken 2007 Review: implications of in vitro research on the effect of radiotherapy and chemotherapy under hypoxic conditions Oncologist 12 690 712 17602059 10.1634/theoncologist.12-6-690 1:CAS:528:DC%2BD2sXosF2gsL4%3D (Pubitemid 47036204)
4. P Stadler A Becker HJ Feldmann G Hänsgen J Dunst F Würschmidt, et al. 1999 Influence of the hypoxic subvolume on the survival of patients with head and neck cancer Int J Radiat Oncol Biol Phys 44 749 754 10386631 10.1016/S0360-3016(99)00115-7 1:STN:280:DyaK1MzhtlajsA%3D%3D (Pubitemid 29284123)
5. 2) during accelerated radiotherapy of head and neck carcinoma Eur J Cancer 34 856 861 9797698 10.1016/S0959-8049(97)10172-1 1:STN:280:DyaK1M%2FhsVCgsA%3D%3D (Pubitemid 28248497)
6. M Hockel K Schlenger B Aral M Mitze U Schaffer P Vaupel, et al. 1996 Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix Cancer Res 56 4509 4515 8813149 1:STN:280: DyaK28vgvVWjtg%3D%3D (Pubitemid 26330463)
7. M Nordsmark J Alsner J Keller OS Nielsen OM Jensen MR Horsman, et al. 2001 Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations Br J Cancer 84 1070 1075 11308256 10.1054/bjoc.2001.1728 1:CAS:528:DC%2BD3MXktFymuro%3D (Pubitemid 32448504)
8. 2 on tumour oxygenation in advanced head and neck tumours Radiother Oncol 66 71 74 12559523 10.1016/S0167-8140(02)00391-2 1:CAS:528: DC%2BD3sXmsV2jsw%3D%3D (Pubitemid 36136006)
9. JD Chapman 1979 Hypoxic sensitizers-implications for radiation therapy N Engl J Med 301 1429 1432 229413 10.1056/NEJM197912273012606 1:STN:280: DyaL3c%2Fnslylug%3D%3D
10. PA Jerabek TB Patrick MR Kilbourn DD Dischino MJ Welch 1986 Synthesis and biodistribution of 18F-labeled fluoronitroimidazoles: potential in vivo markers of hypoxic tissue Int J Rad Appl Instrum A 37 599 605 3021662 10.1016/0883-2889(86)90079-1 1:CAS:528:DyaL28Xls1Sntrk%3D (Pubitemid 17190784)
11. JR Grierson JM Link CA Mathis JS Rasey KA Krohn 1989 A radiosynthesis of fluorine-18 fluoromisonidazole J Nucl Med 30 343 350 2738663 1:CAS:528:DyaK3MXitVWrtA%3D%3D (Pubitemid 19077324)
12. T Yamane M Kikuchi S Shinohara M Senda 2011 Reduction of [(18)F]fluoromisonidazole uptake after neoadjuvant chemotherapy for head and neck squamous cell carcinoma Mol Imaging Biol 13 227 231 20552284 10.1007/s11307-010-0365-2
13. M Kikuchi S Shinohara Y Nakamoto Y Usami K Fujiwara T Adachi, et al. 2011 Sequential FDG-PET/CT after neoadjuvant chemotherapy is a predictor of histopathologic response in patients with head and neck squamous cell carcinoma Mol Imaging Biol 13 368 377 20552285 10.1007/s11307-010-0364-3
14. G Tang M Wang X Tang M Gan L Luo 2005 Fully automated one-pot synthesis of [18F]fluoromisonidazole Nucl Med Biol 32 553 558 15982586 10.1016/j.nucmedbio.2005.03.010 1:CAS:528:DC%2BD2MXlvVWmurk%3D (Pubitemid 40854106)
15. SJ Oh DY Chi C Mosdzianowski JY Kim HS Gil SH Kang, et al. 2005 Fully automated synthesis of [18F]fluoromisonidazole using a conventional [18F]FDG module Nucl Med Biol 32 899 905 16253816 10.1016/j.nucmedbio.2005.06.003 1:CAS:528:DC%2BD2MXhtFKhsbzP (Pubitemid 41505324)
16. SM Eschmann F Paulsen M Reimold H Dittmann S Welz G Reischl, et al. 2005 Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy J Nucl Med. 46 253 260 15695784 (Pubitemid 43073432)
17. LH Gray AD Conger M Ebert S Hornsey OC Scott 1953 The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy Br J Radiol 26 638 648 13106296 10.1259/0007-1285-26-312-638 1:CAS:528:DyaG2cXhvVGjsA%3D%3D
18. JM Brown 1999 The hypoxic cell: a target for selective cancer therapy-eighteenth Bruce F Cain Memorial Award lecture Cancer Res 59 5863 5870 10606224 1:CAS:528:DC%2BD3cXht1SgsA%3D%3D (Pubitemid 30004940)
19. AD Horan CJ Koch 2001 The Km for radiosensitization of human tumor cells by oxygen is much greater than 3 mmHg and is further increased by elevated levels of cysteine Radiat Res 156 388 398 11554850 10.1667/0033-7587(2001) 156[0388:TKMFRO]2.0.CO;2 1:CAS:528:DC%2BD3MXnsFCrt7Y%3D (Pubitemid 32904992)
20. JS Rasey Z Grunbaum S Magee NJ Nelson PL Olive RE Durand, et al. 1987 Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells Radiat Res 111 292 304 3628717 10.2307/3576986 1:CAS:528:DyaL2sXlslWmt70%3D (Pubitemid 17156952)
21. JS Rasey NJ Nelson L Chin ML Evans Z Grunbaum 1990 Characteristics of the binding of labeled fluoromisonidazole in cells in vitro Radiat Res 122 301 308 2356284 10.2307/3577760 1:CAS:528:DyaK3cXksFGisbY%3D (Pubitemid 20214420)
22. JS Rasey WJ Koh ML Evans LM Peterson TK Lewellen MM Graham, et al. 1996 Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients Int J Radiat Oncol Biol Phys 36 417 428 8892467 10.1016/S0360-3016(96)00325-2 1:STN:280: DyaK2s%2FkslGntQ%3D%3D
23. M Nordsmark M Overgaard J Overgaard 1996 Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck Radiother Oncol 41 31 39 8961365 1:CAS:528:DyaK28XntlWiu78%3D (Pubitemid 26396294)
24. Gagel B, Piroth M, Pinkawa M, Reinartz P, Zimny M, Kaiser HJ, et al. pO polarography, contrast enhanced color duplex sonography (CDS), [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography: validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the puzzle of tumor hypoxia? BMC Cancer. 2007;7:113.
25. Gagel B, Reinartz P, Demirel C, Kaiser HJ, Zimny M, Piroth M, et al. [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study. BMC Cancer. 2006;6:51.
26. JL Tatum GJ Kelloff RJ Gillies JM Arbeit JM Brown KS Chao, et al. 2006 Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy Int J Radiat Biol 82 699 757 17118889 10.1080/09553000601002324 1:CAS:528:DC%2BD28XhtlejsbnM (Pubitemid 44832019)
27. K Kubota M Tada S Yamada K Hori S Saito R Iwata, et al. 1999 Comparison of the distribution of fluorine-18 fluoromisonidazole, deoxyglucose and methionine in tumour tissue Eur J Nucl Med 26 750 757 10398823 10.1007/s002590050446 1:CAS:528:DyaK1MXjvFWktb0%3D (Pubitemid 29338663)
28. AM Spence M Muzi KR Swanson F O'Sullivan JK Rockhill JG Rajendran, et al. 2008 Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival Clin Cancer Res 14 2623 2630 18451225 10.1158/1078-0432.CCR-07-4995 1:CAS:528:DC%2BD1cXlsV2qtr8%3D
29. JG Rajendran DL Schwartz J O'Sullivan LM Peterson P Ng J Scharnhorst, et al. 2006 Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer Clin Cancer Res 12 5435 5441 17000677 10.1158/1078-0432.CCR-05-1773 1:CAS:528:DC%2BD28XpvFShsb4%3D (Pubitemid 44497258)
30. D Thorwarth SM Eschmann F Paulsen M Alber 2005 A kinetic model for dynamic [18F]-FMISO PET data to analyse tumour hypoxia Phys Med Biol 50 2209 2224 15876662 10.1088/0031-9155/50/10/002 (Pubitemid 40767811)